Skip to content

The Effect of Local Anesthetic Injection Depth on Procedural Pain and Discomfort During Fluoroscopically Guided Lumbar Transforaminal Epidural Injections

The Effect of Local Anesthetic Injection Depth on Procedural Pain and Discomfort During Fluoroscopically Guided Lumbar Transforaminal Epidural Injections

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03308136
Enrollment
68
Registered
2017-10-12
Start date
2017-10-16
Completion date
2018-02-28
Last updated
2019-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Radiculopathy Due to Spinal Nerve Compression

Keywords

epidural steroid injection, procedural pain, local Anesthetic Injection

Brief summary

Lumbar Transforaminal Epidural Injection is helpful for the treatment of lumbosacral radicular pain. But needle handling during the procedure may cause pain and discomfort to the patient. At the local skin anesthesia step, local anesthetics injection to the muscle layer along the needle pathway as well as the subcutaneous layer may reduce the procedural pain. In addition, it can reduce the injection site pain that may occur after the procedure.

Detailed description

1. A planned Fluoroscopically Guided Lumbar Transforaminal Epidural Injection should be performed after receiving the informed consent of the patient. 2. This study is single-blind because it is not possible to blind the practitioner performing the injection. 3. Subjects were randomly assigned to the subcutaneous anesthesia group (group A) and the muscle anesthesia group (group B) by a random random number table, and the possibilities for belonging to any group were all the same and can not be artificially controlled by researchers. 4. After the procedure, a resident who does not know of this study records the patient's pain and discomfort. and on follow-up visits, post injection site pain is checked. 5. Because of the large difference between the skilled and unskilled patients, the procedure in this study is performed by only one skilled practitioner

Interventions

PROCEDURE1ml of local anesthetics (1% Lidocaine) were injected into the subcutaneous layer.

1\) In group A, 1ml of local anesthetics (1% Lidocaine) were injected into the subcutaneous layer.

PROCEDURE1ml of a local anesthetics (1% idocaine) are first injected into the subcutaneous layer, followed by 3~4ml of local anesthetics to the muscle layer along the expected needle pathway.

2\) In group B, 1ml of a local anesthetics (1% Lidocaine) are first injected into the subcutaneous layer, followed by 3\ 4ml of local anesthetics to the muscle layer along the expected needle pathway.

1% Lidocaine

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Masking description

1. The subjects were randomly assigned to subcutaneous anesthesia group (group A) and muscle anesthesia group (group B), and the assigned results are unknown. 2. The Outcomes Assessor is not related to the study, and does not know its contents.

Intervention model description

subcutaneous anesthesia group (group A) muscle anesthesia group (group B)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1\. Magnetic resonance imaging (MRI) and clinical manifestations of adult men and women over 20 years of age are eligible for radiculopathy due to back nerve root compression and subject to fluoroscopically guided lumbar transforaminal epidural Injection at the suspected spinal nerveroots level.

Exclusion criteria

1. Blood clotting disorder 2. Infection around the site 3. Contrast agent allergy 4. Uncontrolled cardiovascular, cerebrovascular, kidney disease 5. Past history of spinal surgery (ex, spinal fusion) 6. If can not block due to Non-cooperation with subjects (ex, if you can not take the stomach) 7. Patients taking narcotic analgesics

Design outcomes

Primary

MeasureTime frameDescription
Procedural Pain score (NRS)Immediately after the procedureNumeric Rating Scale(NRS) score : from 0 (No pain) to 10 (worst pain imaginable)

Secondary

MeasureTime frameDescription
At the next outpatient visit, whether the injection site pain(Yes) or not(No)2 weeksAt the next outpatient visit, subjects asked about injection site pain (Yes / No) after the last injection.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026